The Declaration of Oviedo: Incorporating Prevention in Drug Policies
Presented at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Search
Research Update from the National Institute on Drug Abuse
Presented at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Empowering Change: Strategies for Navigating Your Policy Advocacy Journey
Presented at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Example of fully functioning digital national infrastructural support IPREV for school and community prevention activities: a compact simple system means understandable, acceptable and sustainable solution
Presented at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Public Health of Addiction
Presentes at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Recovery: The Many Paths to Wellness (Chapter 5 from Facing Addiction in America)
The Many Paths to Wellness: Explore Chapter 5 in "Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health," which defines the concept of recovery from substance use disorders and reviews methods used by...
Extended-release pharmacotherapies for Substance Use Disorders in incarcerated populations
A history of harmful substance use or dependence is common among people in Criminal Justice Systems (CJSs) around the world. The time after an individual has left the CJS is of elevated risk for those with harmful substance use - with high...
Sex and gender differences in HCV risk and cascade of care among people who inject drugs
This seminar explored why it is important to study sex and gender differences in people who inject drugs, with reference to examples relevant to hepatitis C risk and the cascade of care. It included an overview of why we study sex and...
World Drug Report 2023
For the first time since its conception, this year the World Drug Report consists of two products, a web-based element and a set of booklets.
The effects of the cost of living crisis on families and friends of someone with a substance use problem
The impact of addiction on family finances is multiple.
It is therefore no surprise to find that the cost of living crisis is causing additional difficulty and strain to families affected by substance use, adding further complexity to the...
How have governments communicated UK alcohol duty policy changes?
Pricing, including taxation, is a key tool to address harm from alcohol and is identified by the World Health Organization as a ‘best buy’ policy (meaning it is both effective in reducing harm and cost-effective). However alcohol was 72%...
The social context of drinking among LGBT+ people
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
European Drug Report 2023: Trends and Developments
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...
The Role of Law Enforcement Officers in Drug Use Prevention within School Settings A Guiding Document
In the context of law enforcement, the UNODC has developed a guiding document to help support a change of culture on how to make use of the science of prevention for the betterment of the health and safety development of youth.
The UNODC...
« Marketing de l’alcool auprès des personnes LGBTQ+ »
Regardez la vidéo du webinaire « Alcohol Occasionals » du SHAAP/SARN, qui s’est tenu sur Zoom le 24 mai 2023 : « Marketing de l’alcool auprès des personnes LGBTQ+ : Évolution des stratégies pour cibler l’identité », par le Dr David Whiteley...
Hexahydrocannabinol (HHC) and related substances
Introduction
The markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available.
The European situation presented in Section 1 can...
The future of drug monitoring in Europe until 2030
Introduction
Patterns of drug use and developments in the drug market in Europe are becoming more complex and dynamic, with major implications for drug monitoring and research. This observation prompted the European Monitoring Centre for...
Je n’avais rien, et la drogue ne part pas » : Points de vue des jeunes contrevenants sur l’alcool et les autres drogues (AoD)
Ce webinaire s’est penché sur le contexte de la consommation d’alcool et d’autres drogues chez les jeunes contrevenants et sur les répercussions sur les stratégies de réduction des méfaits.
L’importance d’interventions à plusieurs niveaux...
Canada’s Guidance on Alcohol and Health: Final Report
Canada’s Guidance on Alcohol and Health provides evidence-based advice on alcohol to support people in making informed decisions about their health. The guidance is based on the latest research on alcohol-related risks and replaces Canada’s...
EMCDDA webinar: Methamphetamine in Europe — past and present
Objective: To explore the problem of methamphetamine in Europe.
In this webinar, EMCDDA will explore the problem of methamphetamine in Europe, how it is deeply rooted in the history of our continent and how it evolved.